Veronique Damagnez
Inventor
Stats
- 15 US patents issued
- 29 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 15 US Patents Issued
- 29 US Applications Filed
- 237 Total Citation Count
- Oct 16, 2023 Most Recent Filing
- Jun 4, 1993 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| AGENNIX USA INC. | 2
1 2 | 1997
1998 2001 |
| GPC Biotech, Inc. | 1
3 2 1 | 1993
1995 1996 1998 |
| OSCIENT PHARMACEUTICALS CORPORATION | 1
2 | 2002
2007 |
| THE JOHNS HOPKINS UNIVERSITY | 1
| 1997
|
| ARIAD GENE THERAPEUTICS, INC. | 1
1 1 1 | 1994
1998 2004 2009 |
| ARIAD PHARMACEUTICALS, INC. | 2
| 1998
|
| WYETH | 1
2 | 2002
2007 |
Inventor Addresses
| Address | Duration |
|---|---|
| Boston, MA, US | Nov 19, 20 - Oct 10, 24 |
| CAMBRIDGE, MA | Jun 05, 03 - Jun 05, 03 |
| Cambridge, MA | Aug 22, 95 - Mar 17, 05 |
| Cambridge, MA, US | Nov 14, 02 - Mar 17, 11 |
| Framingham, MA | Feb 26, 04 - Jun 07, 07 |
| Framingham, MA, US | Apr 20, 10 - Oct 26, 23 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 7 |
| C07D: | HETEROCYCLIC COMPOUNDS | 10 |
| C07F: | ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM | 3 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2024/0336,614 | 2024 | MODULATORS OF ALPHA-1 ANTITRYPSIN | 0 |
| 2023/0339,915 | 2023 | MODULATORS OF ALPHA-1 ANTITRYPSIN | 0 |
| 2023/0265,080 | 2023 | MODULATORS OF ALPHA-1 ANTITRYPSIN | 0 |
| 2023/0159,580 | 2023 | PYRROLO[2,3-F]INDAZOLE AND 2,4,5,10-TETRAZATRICYCLO[7.3.0.03,7]DODECA-1,3(7),5,8,11-PENTAENE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD) | 0 |
| 2023/0159,521 | 2023 | 1H-PYRAZOLO[4,3-G]ISOQUINOLINE AND 1H-PYRAZOLO[4,3-G]QUINOLINE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD) | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.